DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Omniscan (Gadodiamide) - Life Threatening Events - Suspected Cause - Side Effect Reports

 
 



Index of reports > Life Threatening Events (3)

Below is the selection of side effect reports (a.k.a. adverse event reports) related to Omniscan (Gadodiamide) life threatening events. The selected reports were submitted to the FDA during the sample period of about a year.

Possible Omniscan side effects in 56 year old male

Reported by a consumer/non-health professional from United States on 2012-04-27

Patient: 56 year old male

Reactions: Aphagia, Abasia, Skin Induration, Erythema, Walking AID User, Finger Deformity, Malaise, Joint Swelling, Skin Discolouration, Arthralgia, Oedema Peripheral, Pharyngitis Streptococcal, Urinary Retention, Infection

Adverse event resulted in: life threatening event, hospitalization, disablity

Drug(s) suspected as cause:
Gadolinium IN Unspecified Drug
    Indication: Hepatic Cirrhosis

Omniscan
    Indication: Hepatic Cirrhosis

Gadolinium IN Unspecified Drug
    Dosage: unk
    Indication: Nuclear Magnetic Resonance Imaging
    Start date: 2009-02-24
    End date: 2009-02-24

Omniscan
    Dosage: 20 mg, once
    Indication: Nuclear Magnetic Resonance Imaging
    Start date: 2009-02-24
    End date: 2009-02-24

Other drugs received by patient: Sodium Chloride; Sodium Chloride



Possible Omniscan side effects in male

Reported by a consumer/non-health professional from United States on 2012-03-30

Patient: male, weighing 88.5 kg (194.6 pounds)

Reactions: Myalgia, Pain, Coma, Pyrexia, Unevaluable Event, Erythema

Adverse event resulted in: life threatening event, hospitalization, disablity

Drug(s) suspected as cause:
Omniscan
    Dosage: 20.0 intravenous
    Indication: Imaging Procedure
    Start date: 2009-02-24

Sodium Chloride 0.9%
    Dosage: 40.0 ml intravenous
    Indication: Imaging Procedure
    Start date: 2009-02-24



Possible Omniscan side effects in male

Reported by a physician from Japan on 2012-03-28

Patient: male

Reactions: Morphoea, Joint Contracture, Pain, Joint Range of Motion Decreased, Skin Discolouration, Feeling Hot, Oedema Peripheral, Arteriovenous Fistula Site Complication, Pain in Extremity, Muscular Weakness, Skin Disorder, Calcinosis, Nephrogenic Systemic Fibrosis, Skin Induration, Gait Disturbance, Sclerema

Adverse event resulted in: life threatening event, disablity

Drug(s) suspected as cause:
Omniscan
    Indication: Renal Transplant
    Start date: 2000-07-18
    End date: 2000-07-18

Omniscan
    Indication: Anastomotic Stenosis

Other drugs received by patient: Multiple Unspecified Drugs; Magnevist

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2012